Clinical Trial Update: A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder. [Phase 3]

View source ↗

Summary

Update on long-term safety results from a Phase 3 study of a long-acting injectable risperidone in adults with schizophrenia or schizoaffective disorder; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Risperidone long-acting injectable (risperidone)

Snippet

Sponsor: Janssen, LP | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED